Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain

Go back to Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 0.31 -0.01 (3.13%)
Previous Close $0.32    52 Week High $31.32 
Open $0.32    52 Week Low $13.95 
Day High $0.32    P/E N/A 
Day Low $0.31    EPS $-3.29 
Volume 3,953,163